Medicover AB (publ) Cash Flow Conversion Efficiency

Latest as of September 2025: 0.170x

Medicover AB (publ) cash flow conversion efficiency. Based on the latest financial reports, Medicover AB (publ) (MCOV-B) has a cash flow conversion efficiency ratio of 0.170x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr980.72 Million ≈ $105.54 Million USD) by net assets (Skr5.76 Billion ≈ $619.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Medicover AB (publ) (2005–2024)

Cash flow conversion efficiency of Medicover AB (publ) from 2005 to 2024. This chart illustrates how Medicover AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Medicover AB (publ) (MCOV-B) stock price for real-time trading data and today's change.

Medicover AB (publ) Cash Flow Conversion Ratio Explained

Medicover AB (publ) cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Medicover AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medicover AB (publ) ranked by their cash flow conversion efficiency. Also see Medicover AB (publ) market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	0.048x
Chicony Electronics Co Ltd TW:2385	0.018x
Shandong Humon Smelting Co Ltd SHE:002237	-0.109x
Webull Corp NASDAQ:BULL	0.038x
LEROY SEAFOOD GR.UNSP.ADR F:Z1L0	0.031x
Zhuzhou Hongda Electronics Corp Ltd Class A SHE:300726	-0.001x
Kaynes Technology India Limited NSE:KAYNES	-0.046x
SJVN Limited NSE:SJVN	0.072x

Annual Cash Flow Conversion Efficiency for Medicover AB (publ) (2005–2024)

The table below shows the annual cash flow conversion efficiency of Medicover AB (publ) from 2005 to 2024. Review free cash flow generation of Medicover AB (publ) to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr489.30 Million ≈ $52.66 Million	Skr261.90 Million ≈ $28.18 Million	0.535x	+37.94%
2023-12-31	Skr528.30 Million ≈ $56.85 Million	Skr205.00 Million ≈ $22.06 Million	0.388x	+16.46%
2022-12-31	Skr510.80 Million ≈ $54.97 Million	Skr170.20 Million ≈ $18.32 Million	0.333x	-13.57%
2021-12-31	Skr562.10 Million ≈ $60.49 Million	Skr216.70 Million ≈ $23.32 Million	0.386x	+19.49%
2020-12-31	Skr483.50 Million ≈ $52.03 Million	Skr156.00 Million ≈ $16.79 Million	0.323x	+32.94%
2019-12-31	Skr359.70 Million ≈ $38.71 Million	Skr87.30 Million ≈ $9.39 Million	0.243x	+77.05%
2018-12-31	Skr323.90 Million ≈ $34.86 Million	Skr44.40 Million ≈ $4.78 Million	0.137x	-17.15%
2017-12-31	Skr304.00 Million ≈ $32.72 Million	Skr50.30 Million ≈ $5.41 Million	0.165x	-36.88%
2016-12-31	Skr98.80 Million ≈ $10.63 Million	Skr25.90 Million ≈ $2.79 Million	0.262x	-14.87%
2015-12-31	Skr93.20 Million ≈ $10.03 Million	Skr28.70 Million ≈ $3.09 Million	0.308x	+28.43%
2014-12-31	Skr90.50 Million ≈ $9.74 Million	Skr21.70 Million ≈ $2.34 Million	0.240x	+14.91%
2005-12-31	Skr23.55 Million ≈ $2.53 Million	Skr4.91 Million ≈ $528.82K	0.209x	--

About Medicover AB (publ)

ST:MCOV-B Sweden Medical Care Facilities

Market Cap

$2.27 Billion

Skr21.10 Billion SEK

Market Cap Rank

#5523 Global

#84 in Sweden

Share Price

Skr283.50

Change (1 day)

+1.43%

52-Week Range

Skr182.20 - Skr283.50

All Time High

Skr369.18